Cargando…
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID‐19 cases. On November 24, 2021, B.1.1.5...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693031/ https://www.ncbi.nlm.nih.gov/pubmed/34957469 http://dx.doi.org/10.1002/mco2.110 |
_version_ | 1784619058925142016 |
---|---|
author | He, Xuemei Hong, Weiqi Pan, Xiangyu Lu, Guangwen Wei, Xiawei |
author_facet | He, Xuemei Hong, Weiqi Pan, Xiangyu Lu, Guangwen Wei, Xiawei |
author_sort | He, Xuemei |
collection | PubMed |
description | Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID‐19 cases. On November 24, 2021, B.1.1.529 named Omicron was designated as a variant under monitoring (VUM) by World Health Organization (WHO). Two days later, the Omicron variant was classified as a variant of concern (VOC). This variant harbors a high number of mutations, including 15 mutations in the receptor‐binding domain (RBD) of spike. The Omicron variant also shares several mutations with the previous VOC Alpha, Beta, and Gamma variants, which immediately raised global concerns about viral transmissibility, pathogenicity, and immune evasion. Here we described the discovery and characteristics of the Omicron variant, compared the mutations of the spike in the five VOCs, and further raised possible strategies to prevent and overcome the prevalence of the Omicron variant. |
format | Online Article Text |
id | pubmed-8693031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86930312021-12-22 SARS‐CoV‐2 Omicron variant: Characteristics and prevention He, Xuemei Hong, Weiqi Pan, Xiangyu Lu, Guangwen Wei, Xiawei MedComm (2020) Perspectives Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID‐19 cases. On November 24, 2021, B.1.1.529 named Omicron was designated as a variant under monitoring (VUM) by World Health Organization (WHO). Two days later, the Omicron variant was classified as a variant of concern (VOC). This variant harbors a high number of mutations, including 15 mutations in the receptor‐binding domain (RBD) of spike. The Omicron variant also shares several mutations with the previous VOC Alpha, Beta, and Gamma variants, which immediately raised global concerns about viral transmissibility, pathogenicity, and immune evasion. Here we described the discovery and characteristics of the Omicron variant, compared the mutations of the spike in the five VOCs, and further raised possible strategies to prevent and overcome the prevalence of the Omicron variant. John Wiley and Sons Inc. 2021-12-16 /pmc/articles/PMC8693031/ /pubmed/34957469 http://dx.doi.org/10.1002/mco2.110 Text en © 2021 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspectives He, Xuemei Hong, Weiqi Pan, Xiangyu Lu, Guangwen Wei, Xiawei SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title | SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title_full | SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title_fullStr | SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title_full_unstemmed | SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title_short | SARS‐CoV‐2 Omicron variant: Characteristics and prevention |
title_sort | sars‐cov‐2 omicron variant: characteristics and prevention |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693031/ https://www.ncbi.nlm.nih.gov/pubmed/34957469 http://dx.doi.org/10.1002/mco2.110 |
work_keys_str_mv | AT hexuemei sarscov2omicronvariantcharacteristicsandprevention AT hongweiqi sarscov2omicronvariantcharacteristicsandprevention AT panxiangyu sarscov2omicronvariantcharacteristicsandprevention AT luguangwen sarscov2omicronvariantcharacteristicsandprevention AT weixiawei sarscov2omicronvariantcharacteristicsandprevention |